Search research articles
Contact Us
Filters
Showing results (181-190 of 305) with videos related to
Page
of 31
Sort By:
Journal of Cardiovascular Translational Research
|
April 22, 2021
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure
Roberto Galea, Federico De Marco, Adel Aminian, et al.
The Canadian Journal of Cardiology
|
June 26, 2022
Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks
Antonio Landi, Mattia Branca, Pascal Vranckx, et al.
Cardiovascular Diabetology
|
October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JACC. Cardiovascular Interventions
|
March 12, 2016
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial
Sara Ariotti, Marianna Adamo, Francesco Costa, et al.
International Journal of Cardiology
|
September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trial
Chao Gao, Kuniaki Takahashi, Scot Garg, et al.
American Heart Journal
|
November 2, 2013
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study
Marco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
American Heart Journal
|
June 23, 2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial
Marco Valgimigli, Leonardo Bolognese, Maurizio Anselmi, et al.
European Heart Journal
|
September 10, 2017
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez, Stefan James, Stefan Agewall, et al.
Kardiologia Polska
|
February 20, 2018
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]
Borja Ibanez, Stefan James, Stefan Agewall, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 17, 2021
External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial
Masafumi Ono, Hideyuki Kawashima, Hironori Hara, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 305) with videos related to
Sort By:
Page
of 31
Journal of Cardiovascular Translational Research
|
April 22, 2021
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure
Roberto Galea, Federico De Marco, Adel Aminian, et al.
The Canadian Journal of Cardiology
|
June 26, 2022
Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks
Antonio Landi, Mattia Branca, Pascal Vranckx, et al.
Cardiovascular Diabetology
|
October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JACC. Cardiovascular Interventions
|
March 12, 2016
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial
Sara Ariotti, Marianna Adamo, Francesco Costa, et al.
International Journal of Cardiology
|
September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trial
Chao Gao, Kuniaki Takahashi, Scot Garg, et al.
American Heart Journal
|
November 2, 2013
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study
Marco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
American Heart Journal
|
June 23, 2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial
Marco Valgimigli, Leonardo Bolognese, Maurizio Anselmi, et al.
European Heart Journal
|
September 10, 2017
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez, Stefan James, Stefan Agewall, et al.
Kardiologia Polska
|
February 20, 2018
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]
Borja Ibanez, Stefan James, Stefan Agewall, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 17, 2021
External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial
Masafumi Ono, Hideyuki Kawashima, Hironori Hara, et al.
Page
of 31